OPV vs IPV--could placental immunity reduce the number of vaccine-associated paralytic poliomyelitis?
Fescharek
R
R
Budde
R K
RK
Arras
C
C
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D004334:Drug Administration Schedule; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D007112:Immunity, Maternally-Acquired / Q000276:immunology*; D007115:Immunization Schedule; D007223:Infant; D010920:Placenta / Q000276:immunology*; D011051:Poliomyelitis / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology; D011054:Poliovirus Vaccine, Inactivated / Q000008:administration & dosage / Q000009:adverse effects*; D011055:Poliovirus Vaccine, Oral / Q000008:administration & dosage / Q000009:adverse effects*; D011247:Pregnancy
D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral